Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RepurpSS-II Leflunomide and Hydroxychloroquine Combination Therapy for Primary Sjögren’s Syndrome
2024-510904-36-00Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in primary Sjögren's syndrome comparing Leflunomide + hydroxychloroquine arm with Double placebo arm (2 arms). Started Jun 2024; status: completed.
02
Drugs
hydroxychloroquineleflunomide
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on 2024-510904-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510904-36-00.